Search research articles
Contact Us
Filters
Showing results (151-160 of 221) with videos related to
Page
of 23
Sort By:
Rheumatology (Oxford, England)
|
February 18, 2026
The use of non-TNF targeted biologics in Behçet's Disease: Real-life data from the International AIDA Network Behçet's Disease Registry
Gizem Sevik, Giuseppe Lopalco, Florenzo Iannone, et al.
Rheumatology (Oxford, England)
|
April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritis
Giuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
Rheumatology (Oxford, England)
|
May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry
Jurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Frontiers in Medicine
|
January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry
Antonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Annals of the Rheumatic Diseases
|
March 24, 2026
EULAR recommendations for the management of Behçet's syndrome: 2025 update
Gulen Hatemi, Sofia Ramiro, Yesim Ozguler, et al.
Therapeutic Advances in Musculoskeletal Disease
|
September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network
Carla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Frontiers in Medicine
|
June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry
Giuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Frontiers in Medicine
|
July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network
Antonio Vitale, Laura Obici, Marco Cattalini, et al.
Rheumatology (Oxford, England)
|
August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib
Giuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 221) with videos related to
Sort By:
Page
of 23
Rheumatology (Oxford, England)
|
February 18, 2026
The use of non-TNF targeted biologics in Behçet's Disease: Real-life data from the International AIDA Network Behçet's Disease Registry
Gizem Sevik, Giuseppe Lopalco, Florenzo Iannone, et al.
Rheumatology (Oxford, England)
|
April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritis
Giuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
Rheumatology (Oxford, England)
|
May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry
Jurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Frontiers in Medicine
|
January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry
Antonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Annals of the Rheumatic Diseases
|
March 24, 2026
EULAR recommendations for the management of Behçet's syndrome: 2025 update
Gulen Hatemi, Sofia Ramiro, Yesim Ozguler, et al.
Therapeutic Advances in Musculoskeletal Disease
|
September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network
Carla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Frontiers in Medicine
|
June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry
Giuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Frontiers in Medicine
|
July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network
Antonio Vitale, Laura Obici, Marco Cattalini, et al.
Rheumatology (Oxford, England)
|
August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib
Giuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Page
of 23